Nasdaq, Inc. arrives at its July 23 earnings date with a small but notable shift in analyst sentiment and a month-long build in short positioning — two threads that, taken together, point to a Street growing more selective on valuation even as the bull case on revenue momentum remains intact.
The analyst picture this week is cautiously mixed. Morgan Stanley's Michael Cyprys trimmed his price target from $116 to $112 on July 10, keeping an Overweight rating but signalling less conviction on near-term delivery. Barclays moved in the same direction a day earlier, cutting from $114 to $108 while holding Overweight. Raymond James offered the only offset, nudging its target up to $113 from $111 with a maintained Outperform. The net read: bulls still dominate the consensus, with the Street mean sitting around $106.50 — roughly 21% above the current $88 handle — but the direction of travel on targets is lower. A projected 10% decline in FY26 EPS is the bear camp's central concern, alongside persistent softness in IPO volumes and integration risk from the Adenza acquisition. The bull case rests on 14% year-over-year growth in Market Services and a 25% jump in Financial Crime Management Technology, plus the long-run cross-sell opportunity from the Adenza technology stack.
Short positioning tells a more muted but directionally interesting story. SI has climbed roughly 38% over the past month to 1.65% of free float — still a low absolute level, but the rate of accumulation is worth noting ahead of a print. The borrow market remains effectively open: availability is at maximum capacity, with over 563 million shares available to lend, and cost to borrow is running at just 0.47% — essentially free. The ORTEX short score is holding near 31, flat for two weeks, and availability ranks in the 77th percentile of the universe. This is not a short-pressure setup; it is a gradual, low-conviction lean that reflects caution rather than conviction.
Options positioning sits slightly above its recent baseline but is far from alarming. The put/call ratio is at 0.88 — just 0.29 standard deviations above its 20-day mean of 0.84. For context, the ratio hit 1.03 in late June before retreating; the current level is closer to neutral than defensive. Peers have not moved decisively either way this week: SPGI and ICE both roughly flat to slightly positive, while MCO and FDS underperformed, with FactSet dropping nearly 4% on the day. NDAQ's 1.8% weekly gain is a modest outperformance within the group.
On ownership, the standout detail is Investor AB's continued accumulation. The Swedish investment holding company — already the largest declared shareholder at just over 10% — added 56,782 shares in June at roughly $86, a $4.9 million addition at prices below current levels. That is a meaningful endorsement from a strategic holder. Insider flow elsewhere has been net selling, but the transactions are small and largely routine: the HR Director sold twice, once at $80 and once at $86.91, and the President sold around $92.62 in May. The net 90-day insider position is technically positive — dominated by Investor AB's purchase — rather than reflecting any organic buying from management.
With the Q2 print due July 23, the key tensions are whether Market Services revenue can sustain its momentum into a quarter that saw mixed trading volumes, and whether management updates guidance in a way that addresses the FY26 EPS concern that is now pulling analyst targets lower even among the bulls.
See the live data behind this article on ORTEX.
Open NDAQ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
